AFFIMED N V's ticker is AFMD and the CUSIP is N01045108. A total of 56 filers reported holding AFFIMED N V in Q1 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $4,000 | +100.0% | 1,000 | 0.0% | 0.00% | +100.0% |
Q2 2018 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $2,000 | +100.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $2,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Public Equity Management, LLC | 3,209,013 | $6,578,000 | 0.40% |
Telemetry Investments, L.L.C. | 367,067 | $752,000 | 0.35% |
NEA Management Company, LLC | 3,888,888 | $7,972,000 | 0.29% |
DAFNA Capital Management LLC | 92,500 | $190,000 | 0.14% |
Tekla Capital Management LLC | 1,405,324 | $2,881,000 | 0.11% |
Perceptive Advisors | 668,214 | $1,369,000 | 0.07% |
MUHLENKAMP & CO INC | 72,786 | $149,000 | 0.05% |
Orbimed Advisors | 1,799,700 | $3,689,000 | 0.04% |
MOORE CAPITAL MANAGEMENT, LP | 250,000 | $513,000 | 0.02% |
Baker Brothers Advisors | 400,000 | $820,000 | 0.01% |